STAGE III CHRONIC LYMPHOCYTIC LEUKEMIA
Clinical trials for STAGE III CHRONIC LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new STAGE III CHRONIC LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for STAGE III CHRONIC LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Smarter CMV strategy may protect stem cell transplant patients
Disease control OngoingThis study tested a modified approach to prevent and treat cytomegalovirus (CMV) infection in 153 people with blood cancers who had a donor stem cell transplant. The goal was to see if delaying or adjusting anti-CMV therapy could still keep patients safe while reducing unnecessar…
Matched conditions: STAGE III CHRONIC LYMPHOCYTIC LEUKEMIA
Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 05:45 UTC
-
New hope for seniors with CLL: major study tests best drug combo
Disease control OngoingThis study is for people aged 65 and older with untreated chronic lymphocytic leukemia (CLL). It compares three treatment options: a standard chemo-immunotherapy (bendamustine plus rituximab), a targeted drug plus immunotherapy (ibrutinib plus rituximab), or the targeted drug alo…
Matched conditions: STAGE III CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:42 UTC